These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15185842)
1. Soy isoflavones prevent the ovarian hormone deficiency-associated rise in leukocytes in rats. Soung DY; Khalil DA; Arquitt AB; Smith BJ; Hammond LJ; Droke EA; Lucas EA; Devareddy L; Arjmandi BH Phytomedicine; 2004; 11(4):303-8. PubMed ID: 15185842 [TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones prevent ovariectomy-induced atherosclerotic lesions in Golden Syrian hamster model of postmenopausal hyperlipidemia. Lucas EA; Lightfoot SA; Hammond LJ; Devareddy L; Khalil DA; Daggy BP; Soung do Y; Arjmandi BH Menopause; 2003; 10(4):314-21. PubMed ID: 12851514 [TBL] [Abstract][Full Text] [Related]
3. Combination of genistin and fructooligosaccharides prevents bone loss in ovarian hormone deficiency. Hooshmand S; Juma S; Arjmandi BH J Med Food; 2010 Apr; 13(2):320-5. PubMed ID: 20132047 [TBL] [Abstract][Full Text] [Related]
4. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Arjmandi BH; Getlinger MJ; Goyal NV; Alekel L; Hasler CM; Juma S; Drum ML; Hollis BW; Kukreja SC Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1358S-1363S. PubMed ID: 9848499 [TBL] [Abstract][Full Text] [Related]
5. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Devareddy L; Khalil DA; Smith BJ; Lucas EA; Soung do Y; Marlow DD; Arjmandi BH Bone; 2006 May; 38(5):686-93. PubMed ID: 16406762 [TBL] [Abstract][Full Text] [Related]
6. [Soy isoflavones with supplemental calcium provide protection against the loss of bone mass and influence insulin-like growth factor (IGF)-I after ovariectomy in rat]. Cheng MW; Liu JF; Yi GQ; Zhang XP; Zhu QH; Liu LG Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):328-31. PubMed ID: 17166423 [TBL] [Abstract][Full Text] [Related]
7. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Hertrampf T; Degen GH; Kaid AA; Laudenbach-Leschowsky U; Seibel J; Di Virgilio AL; Diel P Planta Med; 2006 May; 72(6):484-7. PubMed ID: 16773530 [TBL] [Abstract][Full Text] [Related]
8. Ipriflavone modulates IGF-I but is unable to restore bone in rats. Deyhim F; Smith BJ; Soung DY; Juma S; Devareddy L; Arjmandi BH Phytother Res; 2005 Feb; 19(2):116-20. PubMed ID: 15852487 [TBL] [Abstract][Full Text] [Related]
9. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Arjmandi BH; Birnbaum R; Goyal NV; Getlinger MJ; Juma S; Alekel L; Hasler CM; Drum ML; Hollis BW; Kukreja SC Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1364S-1368S. PubMed ID: 9848500 [TBL] [Abstract][Full Text] [Related]
10. Isoflavone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Shiguemoto GE; Rossi EA; Baldissera V; Gouveia CH; de Valdez Vargas GM; de Andrade Perez SE Maturitas; 2007 Jul; 57(3):261-70. PubMed ID: 17368767 [TBL] [Abstract][Full Text] [Related]
11. Combined effects of exercise and soy isoflavone diet on paraoxonase, nitric oxide and aortic apoptosis in ovariectomized rats. Lee J; Cho HS; Kim DY; Cho JY; Chung JS; Lee HK; Seong NH; Kim WK Appetite; 2012 Apr; 58(2):462-9. PubMed ID: 22227066 [TBL] [Abstract][Full Text] [Related]
12. Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy. Kishida T; Mizushige T; Ohtsu Y; Ishikawa S; Nagamoto M; Izumi T; Obata A; Ebihara K Obesity (Silver Spring); 2008 Feb; 16(2):290-7. PubMed ID: 18239635 [TBL] [Abstract][Full Text] [Related]
13. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Devareddy L; Khalil DA; Korlagunta K; Hooshmand S; Bellmer DD; Arjmandi BH Menopause; 2006; 13(4):692-9. PubMed ID: 16837891 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Hidaka S; Okamoto Y; Miyazaki K; Uesugi T Phytother Res; 2003 Feb; 17(2):112-9. PubMed ID: 12601671 [TBL] [Abstract][Full Text] [Related]
15. Influence of soy aglycon isoflavones on bone-related traits and lens protein characteristics of ovariectomized rats and bioactivity performance of osteoprogenitor cells. Lien TF; Chen W; Hsu YL; Chen HL; Chiou RY J Agric Food Chem; 2006 Oct; 54(21):8027-32. PubMed ID: 17032005 [TBL] [Abstract][Full Text] [Related]
16. The effects of supplemental vitamin E on hematological parameters in a rat model of ovarian hormone deficiency. Pourafshar S; Johnson SA; Keshavarz B; Feresin RG; Khalil DA; Chai SC; Arjmandi BH Menopause; 2018 Mar; 25(3):336-342. PubMed ID: 29088013 [TBL] [Abstract][Full Text] [Related]
17. Effect of daidzein, a soy isoflavone, on bone metabolism in Cd-treated ovariectomized rats. Om AS; Shim JY Acta Biochim Pol; 2007; 54(3):641-6. PubMed ID: 17717607 [TBL] [Abstract][Full Text] [Related]
18. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats. Manjanatha MG; Shelton S; Bishop ME; Lyn-Cook LE; Aidoo A Carcinogenesis; 2006 Dec; 27(12):2555-64. PubMed ID: 17127718 [TBL] [Abstract][Full Text] [Related]
19. Dietary soy protein and isoflavones: minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Bahr JM; Nakai M; Rivera A; Walsh J; Evans GL; Lotinun S; Turner RT; Black M; Jeffery EH Menopause; 2005 Mar; 12(2):165-73. PubMed ID: 15772564 [TBL] [Abstract][Full Text] [Related]
20. Effects of soybean isoflavone dosage and exercise on the serum markers of bone metabolism in ovariectomized rats. Liu K; Ma G; Lv G; Zou Y; Wang W; Liu L; Yan P; Liu Y; Jiang L; Liu Y; Liu Z Asia Pac J Clin Nutr; 2007; 16 Suppl 1():193-5. PubMed ID: 17392103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]